FdaApplication
ANDA 213075
Identifiers
- fda_app_no: ANDA213075
Properties
| Property | Value |
|---|---|
| applicant_name | ALEMBIC PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2022-01-03 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | EQ 150MG BASE | TABLET, DELAYED RELEASE;ORAL |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | EQ 200MG BASE | TABLET, DELAYED RELEASE;ORAL |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | EQ 75MG BASE | TABLET, DELAYED RELEASE;ORAL |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | EQ 100MG BASE | TABLET, DELAYED RELEASE;ORAL |
4 products